Global generics and biosimilars industry representatives have celebrated a “historical moment for our industry” after the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) elected the International Generic and Biosimilar Medicines Association (IGBA) as a member of its management committee.
Having joined the ICH as a full member of the general assembly two years ago (Generics bulletin, 24 June 2016, page 1), the IGBA said management committee membership was “an important next step in the IGBA-ICH relationship”